Grantham, Mayo, Van Otterloo & Co (GMO)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-58,506	Closed	-$20.6M	–	695
2023 Q2	$20.6M	Sell	58,506 -37,394	-39%	-$12.6M	0.1%	179
2023 Q1	$30.2M	Sell	95,900 -21,300	-18%	-$6.39M	0.15%	140
2022 Q4	$33.8M	Buy	117,200 +4,200	+4%	+$1.28M	0.18%	121
2022 Q3	$32.7M	Sell	113,000 -500	-0.4%	-$144K	0.19%	106
2022 Q2	$32M	Buy	113,500 +31,400	+38%	+$8.4M	0.17%	112
2022 Q1	$21.4M	Buy	+82,100	New	+$19.5M	0.1%	177
2019 Q2	–	Sell	-3,200	Closed	-$589K	–	780
2019 Q1	$589K	Hold	3,200	–	–	﹤0.01%	562
2018 Q4	$530K	Buy	+3,200	New	+$554K	﹤0.01%	429
2017 Q1	–	Sell	-100,000	Closed	-$7.37M	–	653
2016 Q4	$7.37M	Buy	100,000 +49,700	+99%	+$4.04M	0.04%	216
2016 Q3	$4.39M	Buy	+50,300	New	+$4.75M	0.02%	259